Mark J Foley
CIK 1529196 · President & CEO · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ZLTQ price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1 GLAUKOS WAY
ALISO VIEJO, CA 92656
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GKOS | Director | 60,267 | $181.00 | $10.91M | -$2.92M | 19 | 2026-06-23 |
| Revance Therapeutics, Inc. (RVNC) Delisted | President & CEO | 27,933 | $3.65 | $102.0K | -$5.60M | 34 | 2025-02-06 |
| SIBN | Director | 8,797 | $21.85 | $192.2K | $0 | 2 | 2020-06-18 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | President and CEO | 0 | — | — | -$21.52M | 67 | 2017-04-28 |
Recent Filings · Page 13 of 13
129 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-02-14 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Tax (F) | −4,667 | -$89.3K | EDGAR |
| 2014-01-21 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Tax (F) | −56,130 | -$1.13M | EDGAR |
| 2013-12-16 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Tax (F) | −4,586 | -$81.7K | EDGAR |
| 2013-11-15 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Tax (F) | −3,361 | -$56.4K | EDGAR |
| 2013-10-16 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Tax (F) | −38,061 | -$355.1K | EDGAR |
| 2013-10-15 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Tax (F) | −38,061 | -$355.1K | EDGAR |
| 2012-08-28 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Grant (A) | +715,548 | $0 | EDGAR |
| 2012-06-18 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-05-01 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Grant (A) | +128,351 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.